Last checked at 4 Dec 2020 13:27
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | WILLIS TOWERS WATSON PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 03 December 2020 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
3,041,150 | 2.36% | 609,136 | 0.47% | ||
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
|
285,403 | 0.22% | 739,005 | 0.57% | ||
|
|
|
| ||
(3) | Options and agreements to |
|
|
|
|
| purchase/sell: | 0 | 0.00% | 0 | 0.00% | |
|
|
|
| ||
| TOTAL: |
|
|
|
| |
3,326,553 | 2.58% | 1,348,141 | 1.05% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 213.0700 USD |
| Purchase | 8 | 212.5425 USD |
| Purchase | 9 | 211.5200 USD |
| Purchase | 14 | 213.1092 USD |
| Purchase | 14 | 213.1014 USD |
| Purchase | 17 | 213.0117 USD |
| Purchase | 22 | 212.8393 USD |
| Purchase | 22 | 212.9500 USD |
| Purchase | 22 | 212.8463 USD |
| Purchase | 24 | 212.7600 USD |
| Purchase | 26 | 212.7651 USD |
| Purchase | 26 | 212.8353 USD |
| Purchase | 28 | 212.7242 USD |
| Purchase | 28 | 212.9089 USD |
| Purchase | 29 | 212.7172 USD |
| Purchase | 31 | 212.6114 USD |
| Purchase | 38 | 212.9831 USD |
| Purchase | 42 | 213.1883 USD |
| Purchase | 83 | 213.0727 USD |
| Purchase | 84 | 213.2466 USD |
| Purchase | 100 | 212.6200 USD |
| Purchase | 100 | 211.0000 USD |
| Purchase | 100 | 212.5900 USD |
| Purchase | 105 | 212.6842 USD |
| Purchase | 125 | 212.2800 USD |
| Purchase | 138 | 212.2139 USD |
| Purchase | 154 | 213.0931 USD |
| Purchase | 162 | 213.1116 USD |
| Purchase | 190 | 212.8946 USD |
| Purchase | 236 | 212.8511 USD |
| Purchase | 273 | 213.0561 USD |
| Purchase | 309 | 212.8138 USD |
| Purchase | 400 | 213.0000 USD |
| Purchase | 500 | 212.8176 USD |
| Purchase | 702 | 212.6962 USD |
| Purchase | 1,030 | 212.8541 USD |
| Purchase | 1,153 | 212.4964 USD |
| Purchase | 1,279 | 212.8200 USD |
| Purchase | 1,723 | 212.7663 USD |
| Purchase | 1,871 | 212.5475 USD |
| Purchase | 1,900 | 212.1471 USD |
| Purchase | 2,331 | 212.7085 USD |
| Purchase | 2,535 | 212.7628 USD |
| Purchase | 2,954 | 212.7143 USD |
| Purchase | 5,698 | 212.8830 USD |
| Purchase | 7,426 | 212.8261 USD |
| Sale | 1 | 212.8800 USD |
| Sale | 2 | 213.0950 USD |
| Sale | 3 | 211.6000 USD |
| Sale | 3 | 213.0400 USD |
| Sale | 3 | 212.9566 USD |
| Sale | 4 | 212.8000 USD |
| Sale | 12 | 212.9783 USD |
| Sale | 15 | 213.0993 USD |
| Sale | 100 | 210.3850 USD |
| Sale | 100 | 213.6500 USD |
| Sale | 125 | 212.2800 USD |
| Sale | 293 | 213.6806 USD |
| Sale | 400 | 211.4475 USD |
| Sale | 467 | 212.9416 USD |
| Sale | 474 | 212.8189 USD |
| Sale | 554 | 212.8183 USD |
| Sale | 1,097 | 212.9069 USD |
| Sale | 1,142 | 212.7639 USD |
| Sale | 1,580 | 211.9146 USD |
| Sale | 1,604 | 212.5957 USD |
| Sale | 1,885 | 212.6759 USD |
| Sale | 3,317 | 212.9114 USD |
| Sale | 4,208 | 212.9505 USD |
| Sale | 6,737 | 212.8200 USD |
| Sale | 10,000 | 212.7148 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 4 Dec 2020 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected |
|
| If a connected EFM, state nature of connection |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20201204005332/en/
Copyright Business Wire 2020